Detalhe da pesquisa
1.
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Am J Respir Crit Care Med
; 209(3): 262-272, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38016003
2.
International severe asthma registry (ISAR): protocol for a global registry.
BMC Med Res Methodol
; 20(1): 212, 2020 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32819285
3.
Oral corticosteroids in asthma and beyond: moving forward.
Eur Respir J
; 60(3)2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36109044
4.
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma.
Front Immunol
; 15: 1361891, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38711495
5.
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy.
J Asthma Allergy
; 15: 1491-1510, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36303891
6.
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study.
J Asthma Allergy
; 15: 63-78, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35046670
7.
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.
J Allergy Clin Immunol Pract
; 10(5): 1202-1216.e23, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34990866
8.
Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities.
J Allergy Clin Immunol Pract
; 9(12): 4353-4370, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34403837
9.
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry.
J Allergy Clin Immunol Pract
; 9(7): 2680-2688.e7, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33744476
10.
Potential Severe Asthma Hidden in UK Primary Care.
J Allergy Clin Immunol Pract
; 9(4): 1612-1623.e9, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33309935
11.
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Chest
; 160(3): 814-830, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33887242
12.
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
World Allergy Organ J
; 13(12): 100490, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33376573
13.
Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.
Chest
; 157(4): 790-804, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31785254
14.
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
J Allergy Clin Immunol Pract
; 12(2): 536-539, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38336403